Anna Rea - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Anna Rea

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Experimental & Clinical Cancer Research : CR|January 3, 2024

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancerSara Santana-Hernández, Jesús Suarez-Olmos, Sonia Servitja, et al.

Blood|September 11, 2020

Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcomeRosaura Esteve-Puig, Fina Climent, David Piñeyro, et al.

Nature Immunology|March 22, 2025

Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppressionAnna Rea, Sara Santana-Hernández, Javier Villanueva, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Experimental & Clinical Cancer Research : CR|January 3, 2024

NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancerSara Santana-Hernández, Jesús Suarez-Olmos, Sonia Servitja, et al.

Blood|September 11, 2020

Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcomeRosaura Esteve-Puig, Fina Climent, David Piñeyro, et al.

Nature Immunology|March 22, 2025

Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppressionAnna Rea, Sara Santana-Hernández, Javier Villanueva, et al.

Pageof 2